4Suppliers
2Customers
1Debt Items
20Related Chains

argenx SE Suppliers

TickerNameConfidenceEvidence
ABBV AbbVie Inc. 80% We currently have collaborative research relationships with various pharmaceutical companies such as AbbVie
ABBV AbbVie Inc. 80% Reciprocal relationship from ABBV graph: Reciprocal relationship from ARGX graph: Reciprocal relationship from ABBV graph: Reciprocal relationship from ARGX graph: Reciprocal relationship from ABBV g…
ZAI-LAB ZAI-LAB 80% We currently have collaborative research relationships with various pharmaceutical companies such as AbbVie, Zai Lab
IMVT Immunovant, Inc. 72% Reciprocal relationship from IMVT graph: gulated, unapproved and off-label treatments. Even if a biosimilar product is less effective than our product candidates, a less effective biosimilar may be m…

argenx SE Customers

TickerNameConfidenceEvidence
VYVGART VYVGART 90% We also have distribution agreements in place with several distribution partners for VYVGART
IMVT Immunovant, Inc. 72% Reciprocal relationship from IMVT graph: gulated, unapproved and off-label treatments. Even if a biosimilar product is less effective than our product candidates, a less effective biosimilar may be m…

argenx SE Debt Obligations

InstrumentDescriptionConfidenceEvidence
ARGX-DEBT Debt stack $47.2M 90% Market cache reports total debt of $47.2M.

argenx SE Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for argenx SE.

argenx SE Ownership

HolderNameConfidenceEvidence
ARGX-OWNER-JANUS-HENDERSON-GROUP-PLC JANUS HENDERSON GROUP PLC 90% 13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 480 tracked holders.

argenx SE Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SNNUF Smith & Nephew plc 100.00 2
ALC Alcon Inc. 100.00 2
CCCC C4 Therapeutics, Inc. 100.00 2
CHRS Coherus Oncology, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
BLLN BillionToOne, Inc. 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
CSTE Caesarstone Ltd. 100.00 2
AORT Artivion, Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
CRBP Corbus Pharmaceuticals Holdings, Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
DEO Diageo plc 100.00 2
BNBX BNB Plus Corp. 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2